Literature DB >> 15571170

Severe acute respiratory syndrome (SARS): over 100 days into the outbreak.

.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 15571170

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  7 in total

Review 1.  Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target.

Authors:  Young-Sam Keum; Yong-Joo Jeong
Journal:  Biochem Pharmacol       Date:  2012-08-23       Impact factor: 5.858

2.  Beyond knowledge: Evaluating the practices and precautionary measures towards COVID-19 amongst medical doctors in Jordan.

Authors:  Mohannad Ramadan; Zuheir Hasan; Tareq Saleh; Mahmoud Jaradat; Mohammad Al-Hazaimeh; Omar Bani Hani; Ala'a B Al-Tammemi; Enas Shorman; Abdel-Hameed Al-Mistarehi; Khalid Kheirallah
Journal:  Int J Clin Pract       Date:  2021-03-17       Impact factor: 3.149

3.  Detection of SARS coronavirus in patients with suspected SARS.

Authors:  Kwok H Chan; Leo L L M Poon; V C C Cheng; Yi Guan; I F N Hung; James Kong; Loretta Y C Yam; Wing H Seto; Kwok Y Yuen; Joseph S Malik Peiris
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

4.  Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year follow-up study.

Authors:  Xia Hong; Glenn W Currier; Xiaohui Zhao; Yinan Jiang; Wei Zhou; Jing Wei
Journal:  Gen Hosp Psychiatry       Date:  2009-08-27       Impact factor: 3.238

Review 5.  Severe Acute Respiratory Syndrome (SARS).

Authors:  J S M Peiris
Journal:  J Clin Virol       Date:  2003-12       Impact factor: 3.168

Review 6.  Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection.

Authors:  A Berger; Ch Drosten; H W Doerr; M Stürmer; W Preiser
Journal:  J Clin Virol       Date:  2004-01       Impact factor: 3.168

7.  Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents.

Authors:  Hiroaki Kariwa; Nobuhiro Fujii; Ikuo Takashima
Journal:  Dermatology       Date:  2006       Impact factor: 5.366
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.